Mao Chung Chang
Direktor/Vorstandsmitglied bei SYNEURX INTERNATIONAL (TAIWAN) CORP.
Profil
Mao Chung Chang is currently a Director at SyneuRx International (Taiwan) Corp.
and a Professor at the University of California, Los Angeles.
Previously, he worked as a Director at Wintek Corp.
Dr. Chang received his graduate and doctorate degrees from National Chiao Tung University and his undergraduate degree from National Taiwan University.
Aktive Positionen von Mao Chung Chang
| Unternehmen | Position | Beginn |
|---|---|---|
| SYNEURX INTERNATIONAL (TAIWAN) CORP. | Direktor/Vorstandsmitglied | 01.07.2020 |
| University of California, Los Angeles | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Mao Chung Chang
| Unternehmen | Position | Ende |
|---|---|---|
| WINTEK CORPORATION | Direktor/Vorstandsmitglied | - |
Ausbildung von Mao Chung Chang
| National Chiao Tung University | Doctorate Degree |
| National Taiwan University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Wintek Corp.
 Wintek Corp. Computer PeripheralsElectronic Technology Wintek Corp. engages in the research, development, design, manufacture and sales of liquid crystal displays (LCD), liquid crystal modules (LCM) and touch panels. Its products include touch panels, light guides, thin film transistor LCD & LCM, lighting and organic light-emitting diode. It was founded on April 26, 1990 and is headquartered in Taichung, Taiwan. | Electronic Technology |
SyneuRx International (Taiwan) Corp.
 SyneuRx International (Taiwan) Corp. BiotechnologyHealth Technology SyneuRx International (Taiwan) Corp. engages in the manufacture and sale of medicines. It offers different kinds of medicines, which are useful for brain disorders like schizophrenia have largely failed to materialize and mental illnesses like depression, obsessive compulsive disorder, attention deficit hyperactivity disorder, autism and dementia. The company was founded by Kuo Chuan Tsai on April 2, 2013 and is headquartered in New Taipei, Taiwan. | Health Technology |
